NCT05516875View on ClinicalTrials.gov

Open-Label Extension Study of ASTORIA

PHASE2TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

January 19, 2024

Primary Completion Date

May 22, 2024

Study Completion Date

June 27, 2024

Conditions

Dyskinesias

Interventions

DRUG

JM-010

JM-010

Trial Locations (2)

Unknown

Contera Investigational site_IT, Roma

Contera Investigational site_ES, Madrid

Sponsors

Lead Sponsor

Contera Pharma A/S

All Listed Sponsors

lead

Contera Pharma A/S

INDUSTRY

NCT05516875 - Open-Label Extension Study of ASTORIA | Biotech Hunter | Biotech Hunter